Efficacy and safety of oral anticoagulation in elderly patients with atrial fibrillation
Authors:
Open Access
- 1 January 2018
- journal article
- review article
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 19 (1) , 67-71
Abstract
Elderly patients with atrial fibrillation are at a higher risk of both ischemic and bleeding events compared with younger patients; therefore, balancing risks and benefits of antithrombotic strategies in this population is crucial. Recent studies have shown that because the risk of stroke increases with age more than the risk of bleeding, the absolute benefit of oral anticoagulation is the highest in elderly patients in whom it outweighs the risk of bleeding. Direct oral anticoagulants (DOACs) have been developed as a treatment for the prevention of cardioembolic stroke to overcome some limitations of warfarin, such as the need for frequent monitoring, labile INR values requiring frequent dose adjustment, dietary and drugs interactions, and increased risk of intracranial bleeding. Despite the better safety profiles of DOACs compared with warfarin, elderly patients often remain undertreated because of the fear of bleeding complications. This review summarizes current evidence regarding the risks of thromboembolisms and bleeding in different antithrombotic strategies in elderly patients (aged ≥75 years) with atrial fibrillation, including data from the warfarin-controlled phase 3 DOACs trials.Keywords
This publication has 33 references indexed in Scilit:
- Heart Disease and Stroke Statistics—2013 UpdateCirculation, 2013
- Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic reviewAge and Ageing, 2011
- Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial FibrillationCirculation, 2011
- Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based ApproachChest, 2010
- Effect of Age on Stroke Prevention Therapy in Patients With Atrial FibrillationStroke, 2009
- The impact of frailty on the utilisation of antithrombotic therapy in older patients with atrial fibrillationAge and Ageing, 2008
- Barriers to the Use of Anticoagulation for Nonvalvular Atrial FibrillationStroke, 2008
- Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial FibrillationAnnals of Internal Medicine, 2007
- Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future PrevalenceCirculation, 2006
- Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.Stroke, 1991